Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Shares Issued (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Shares Issued for 4 consecutive years, with $120000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Shares Issued fell 67.21% to $120000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was -$482000.0, a 224.55% decrease, with the full-year FY2024 number at $141000.0, down 72.67% from a year prior.
  • Shares Issued was $120000.0 for Q1 2025 at Century Therapeutics, up from -$602000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $26.7 million in Q3 2022 to a low of -$602000.0 in Q4 2024.
  • A 4-year average of $2.3 million and a median of $122000.0 in 2023 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 589.23% in 2023; the steepest drop was 98.88% in 2023.
  • Century Therapeutics' Shares Issued stood at $26.7 million in 2022, then tumbled by 101.33% to -$356000.0 in 2023, then tumbled by 69.1% to -$602000.0 in 2024, then surged by 119.93% to $120000.0 in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Shares Issued are $120000.0 (Q1 2025), -$602000.0 (Q4 2024), and $273000.0 (Q3 2024).